Pregnancy and the lungs

Bhatia, Praveen; Bhatia, Karishma

doi:10.1136/pmj.76.901.683

Cited by 52 publications

(34 citation statements)

References 35 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…During the 1957 global influenza pandemic, pregnant women had higher mortality rates from influenza-related pneumonia than nonpregnant women. 17,18 Furthermore, to tolerate fetal antigens during pregnancy, evidence suggests that the maternal immune system suppresses cell-mediated immunity, which increases susceptibility to intracellular pathogens such as viruses and bacteria. 10 In a review of data from the 1975 to 1979 influenza seasons, researchers found that pregnant women had 2.3 times higher rates of outpatient consultations for acute respiratory diseases than nonpregnant women.…”

mentioning

confidence: 99%

A Comprehensive Review of Influenza and Influenza Vaccination During Pregnancy

Yuen¹,

Tarrant²

2014

Journal of Perinatal &Amp; Neonatal Nursing

View full text Add to dashboard Cite

Influenza is a highly infectious respiratory disease that can impose significant health risks leading to increased morbidity and mortality. Receiving influenza vaccination is the most important and effective means of preventing the infection and its related complications. During pregnancy, physiological changes increase susceptibility to influenza infection, and women contracting infectious diseases during pregnancy are more likely to have adverse pregnancy and neonatal outcomes. Influenza vaccination during pregnancy is safe for both pregnant women and their fetus, and pregnant women are now the highest priority group for vaccination. Despite the accumulated evidence of the benefits and safety of influenza vaccination during pregnancy, uptake among pregnant women remains suboptimal. Concerns about the vaccine's safety persist, and the fear of birth defects remains the predominant barrier to vaccination. Targeted interventions have been shown effective in enhancing influenza vaccination uptake among pregnant women. Reluctance to be vaccinated should be addressed by offering accurate information to counteract the misperceptions about the risk of influenza infection during pregnancy as well as to educate mothers about the safety and benefits of influenza vaccination. High-quality randomized controlled trials are recommended to evaluate the effectiveness of individual or multifaceted approaches to increase vaccine uptake.

show abstract

mentioning

confidence: 99%

A Comprehensive Review of Influenza and Influenza Vaccination During Pregnancy

Yuen¹,

Tarrant²

2014

Journal of Perinatal &Amp; Neonatal Nursing

View full text Add to dashboard Cite

show abstract

“…Adjustments in bodyweight need to be considered, because the dose of therapy will require titration accordingly. Despite the multiple physiological changes that occur in pregnancy, the respiratory flow rates (FEV1 and Peek Expiratory Flow Rate (PEFR)) are mostly unchanged in normal pregnancy . While not on ERT, however, women may be at risk of respiratory muscle functional decline .…”

Section: Discussionmentioning

confidence: 99%

“…Despite the multiple physiological changes that occur in pregnancy, the respiratory flow rates (FEV1 and Peek Expiratory Flow Rate (PEFR)) are mostly unchanged in normal pregnancy. 7 While not on ERT, however, women may be at risk of respiratory muscle functional decline. 8 Special attention to ongoing monitoring of respiratory function is essential, with the addition of investigations such as sleep study if clinically indicated (with attention to signs such as early morning headaches).…”

Section: During Pregnancymentioning

confidence: 99%

Pregnancy and associated events in women receiving enzyme replacement therapy for late‐onset glycogen storage disease type II (Pompe disease)

Rohman

Scott

Richfield

et al. 2016

J of Obstet and Gynaecol

View full text Add to dashboard Cite

show abstract

“…In cases with uncertain findings, amniocentesis should be discussed with family members, since the results of these screenings may influence their decisions [17]. In addition, laboratory tests including complete blood cell count, electrolytes such as Na + , Ca 2+ , K + , creatinine, urea, liver enzymes, retinol-binding proteins, albumin, prealbumin, transferrin and urine analysis should be periodically performed.…”

Section: Discussionmentioning

confidence: 99%

One life ends, another begins: Management of a brain-dead pregnant mother-A systematic review-

Esmaeilzadeh

Dictus

Kayvanpour

et al. 2010

BMC Med

123

View full text Add to dashboard Cite

BackgroundAn accident or a catastrophic disease may occasionally lead to brain death (BD) during pregnancy. Management of brain-dead pregnant patients needs to follow special strategies to support the mother in a way that she can deliver a viable and healthy child and, whenever possible, also be an organ donor. This review discusses the management of brain-dead mothers and gives an overview of recommendations concerning the organ supporting therapy.MethodsTo obtain information on brain-dead pregnant women, we performed a systematic review of Medline, EMBASE and the Cochrane Central Register of Controlled Trials (CENTRAL). The collected data included the age of the mother, the cause of brain death, maternal medical complications, gestational age at BD, duration of extended life support, gestational age at delivery, indication of delivery, neonatal outcome, organ donation of the mothers and patient and graft outcome.ResultsIn our search of the literature, we found 30 cases reported between1982 and 2010. A nontraumatic brain injury was the cause of BD in 26 of 30 mothers. The maternal mean age at the time of BD was 26.5 years. The mean gestational age at the time of BD and the mean gestational age at delivery were 22 and 29.5 weeks, respectively. Twelve viable infants were born and survived the neonatal period.ConclusionThe management of a brain-dead pregnant woman requires a multidisciplinary team which should follow available standards, guidelines and recommendations both for a nontraumatic therapy of the fetus and for an organ-preserving treatment of the potential donor.

show abstract

Pregnancy and the lungs

Cited by 52 publications

References 35 publications

A Comprehensive Review of Influenza and Influenza Vaccination During Pregnancy

A Comprehensive Review of Influenza and Influenza Vaccination During Pregnancy

Pregnancy and associated events in women receiving enzyme replacement therapy for late‐onset glycogen storage disease type II (Pompe disease)

One life ends, another begins: Management of a brain-dead pregnant mother-A systematic review-

Contact Info

Product

Resources

About